{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:51:01Z","timestamp":1790826661839,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microb Cell Fact"],"DOI":"10.1186\/s12934-025-02694-0","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T17:35:48Z","timestamp":1747762548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development of a set of bacterial engineered glycoconjugates as novel serogroup-specific antigens for the serodiagnosis of Escherichia coli O26, O111, O103 and O45 infections associated to hemolytic uremic syndrome"],"prefix":"10.1186","volume":"24","author":[{"given":"Ana J.","family":"Caillava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano J.","family":"Melli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malena","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella Maris","family":"Landivar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Chinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia S.","family":"Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan E.","family":"Ugalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego J.","family":"Comerci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s E.","family":"Ciocchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"2694_CR1","doi-asserted-by":"crossref","unstructured":"Torres AG. Escherichia coli in the Americas. 1st ed. Torres A (2013) Escherichia coli in the Americas. Switzerland: Springer Cham.","DOI":"10.2174\/978160805192211001010001"},{"key":"2694_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/ilar.51.3.221","volume":"51","author":"A Garc\u00eda","year":"2010","unstructured":"Garc\u00eda A, Fox JG, Besser TE. Zoonotic Enterohemorrhagic escherichia coli: a one health perspective. ILAR J. 2010;51:221\u201332.","journal-title":"ILAR J"},{"key":"2694_CR3","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1086\/509573","volume":"43","author":"JM Hughes","year":"2006","unstructured":"Hughes JM, Wilson ME, Johnson KE, Thorpe CM, Sears CL. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis. 2006;43:1587.","journal-title":"Clin Infect Dis"},{"key":"2694_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed7110356","author":"MG Alharbi","year":"2022","unstructured":"Alharbi MG, Al-Hindi RR, Esmael A, Alotibi IA, Azhari SA, Alseghayer MS, et al. The \u201cbig six\u201d: hidden emerging foodborne bacterial pathogens. Trop Med Infect Dis. 2022. https:\/\/doi.org\/10.3390\/tropicalmed7110356.","journal-title":"Trop Med Infect Dis"},{"key":"2694_CR5","doi-asserted-by":"crossref","unstructured":"The European union one health 2022 Zoonoses Report. EFSA Journal. 2023;21","DOI":"10.2903\/j.efsa.2023.p211202"},{"key":"2694_CR6","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1056\/NEJMra2108739","volume":"389","author":"SB Freedman","year":"2023","unstructured":"Freedman SB, van de Kar NCAJ, Tarr PI. Shiga toxin-producing Escherichia coli and the hemolytic-uremic syndrome. N Engl J Med. 2023;389:1402\u201314.","journal-title":"N Engl J Med"},{"key":"2694_CR7","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/S0140-6736(22)01202-8","volume":"400","author":"M Michael","year":"2022","unstructured":"Michael M, Bagga A, Sartain SE, Smith RJH. Haemolytic uraemic syndrome. The Lancet. 2022;400:1722\u201340.","journal-title":"The Lancet"},{"key":"2694_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2017.09.012","author":"M Bruyand","year":"2018","unstructured":"Bruyand M, Mariani-Kurkdjian P, Gouali M, de Valk H, King LA, Le Hello S, et al. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection. Med Mal Infect. 2018. https:\/\/doi.org\/10.1016\/j.medmal.2017.09.012.","journal-title":"Med Mal Infect"},{"key":"2694_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14489","author":"ML Monteverde","year":"2023","unstructured":"Monteverde ML, Panero N, Chaparro AB, Locane F, Sarkis C, Mattio SA, et al. A decrease in the incidence of Shiga toxin-related hemolytic uremic syndrome as a cause of kidney transplantation at an argentine referral center. Pediatr Trans. 2023. https:\/\/doi.org\/10.1111\/petr.14489.","journal-title":"Pediatr Trans."},{"key":"2694_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00478","author":"BD Parsons","year":"2016","unstructured":"Parsons BD, Zelyas N, Berenger BM, Chui L. Detection, characterization, and typing of shiga toxin-producing Escherichia coli. Front Microbiol. 2016. https:\/\/doi.org\/10.3389\/fmicb.2016.00478.","journal-title":"Front Microbiol."},{"key":"2694_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clinmicnews.2012.04.004","volume":"34","author":"LH Gould","year":"2012","unstructured":"Gould LH, Bopp C, Strockbine N, Atkinson R, Baselski V, Body B, et al. Update: recommendations for diagnosis of Shiga Toxin-producing Escherichia coli infections by clinical laboratories. Clin Microbiol Newsl. 2012;34:75\u201383.","journal-title":"Clin Microbiol Newsl"},{"key":"2694_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2013.12.002","author":"G Ardissino","year":"2014","unstructured":"Ardissino G, Possenti I, Tel F, Testa S, Paglialonga F. Time to change the definition of hemolytic uremic syndrome. Eur J Intern Med. 2014. https:\/\/doi.org\/10.1016\/j.ejim.2013.12.002.","journal-title":"Eur J Intern Med."},{"key":"2694_CR13","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00467-016-3420-7","volume":"31","author":"KL Wijnsma","year":"2016","unstructured":"Wijnsma KL, van Bommel SAM, van der Velden T, Volokhina E, Schreuder MF, van den Heuvel LP, et al. Fecal diagnostics in combination with serology: best test to establish STEC-HUS. Pediatr Nephrol. 2016;31:2163\u201370.","journal-title":"Pediatr Nephrol"},{"key":"2694_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-4118-9","author":"KL Wijnsma","year":"2018","unstructured":"Wijnsma KL, Veissi ST, van Bommel SAM, Heuver R, Volokhina EB, Comerci DJ, et al. Glyco-iELISA: a highly sensitive and unambiguous serological method to diagnose STEC-HUS caused by serotype O157. Pediat Nephrol. 2018. https:\/\/doi.org\/10.1007\/s00467-018-4118-9.","journal-title":"Pediat Nephrol."},{"key":"2694_CR15","first-page":"345","volume":"55","author":"M Rivas","year":"2023","unstructured":"Rivas M, Pichel M, Colonna M, Casanello AL, Alconcher LF, Galavotti J, et al. Surveillance of Shiga toxin-producing Escherichia coli associated bloody diarrhea in Argentina. Rev Argent Microbiol. 2023;55:345\u201354.","journal-title":"Rev Argent Microbiol."},{"key":"2694_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00467-022-05671-6","volume":"38","author":"GA Fiorentino","year":"2023","unstructured":"Fiorentino GA, Miliwebsky E, Ramos MV, Zolezzi G, Chinen I, Guzm\u00e1n G, et al. Etiological diagnosis of post-diarrheal hemolytic uremic syndrome (HUS): humoral response contribution. Pediatr Nephrol. 2023;38:739\u201348.","journal-title":"Pediatr Nephrol."},{"key":"2694_CR17","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1128\/jcm.30.5.1174-1178.1992","volume":"30","author":"M Bitzan","year":"1992","unstructured":"Bitzan M, Karch H. Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome. J Clin Microbiol. 1992;30:1174\u20138.","journal-title":"J Clin Microbiol"},{"key":"2694_CR18","doi-asserted-by":"publisher","first-page":"30170","DOI":"10.2807\/1560-7917.ES.2016.21.11.30170","volume":"21","author":"E Peron","year":"2016","unstructured":"Peron E, Zaharia A, Zota LC, Severi E, M\u00e5rdh O, Usein C, et al. Early findings in outbreak of haemolytic uraemic syndrome among young children caused by Shiga toxin-producing Escherichia coli, Romania, January to February 2016. Eurosurveillance. 2016;21:30170.","journal-title":"Eurosurveillance"},{"key":"2694_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1128\/jcm.27.2.285-290.1989","volume":"27","author":"H Chart","year":"1989","unstructured":"Chart H, Scotland SM, Rowe B. Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome. J Clin Microbiol. 1989;27:285\u201390.","journal-title":"J Clin Microbiol"},{"key":"2694_CR20","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1128\/JCM.03469-13","volume":"52","author":"J Isobe","year":"2014","unstructured":"Isobe J, Shima T, Kanatani JI, Kimata K, Shimizu M, Kobayashi N, et al. Serodiagnosis using microagglutination assay during the food-poisoning outbreak in Japan caused by consumption of raw beef contaminated with enterohemorrhagic Escherichia coli O111 and O157. J Clin Microbiol. 2014;52:1112\u20138.","journal-title":"J Clin Microbiol"},{"key":"2694_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0140-6736(91)90801-U","volume":"337","author":"H Chart","year":"1991","unstructured":"Chart H, Smith HR, Scotland SM, Rowe B, Milford DV, Taylor CM. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet. 1991;337:138\u201340.","journal-title":"Lancet"},{"key":"2694_CR22","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/jcm.32.5.1172-1178.1994","volume":"32","author":"JS Greatorex","year":"1994","unstructured":"Greatorex JS, Thorne GM. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects. J Clin Microbiol. 1994;32:1172\u20138.","journal-title":"J Clin Microbiol"},{"key":"2694_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/lam.13295","volume":"70","author":"W Rastawicki","year":"2020","unstructured":"Rastawicki W, \u015amieta\u0144ska K, Rokosz-Chudziak N, Wo\u0142kowicz T. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland. Lett Appl Microbiol. 2020;70:440\u20136.","journal-title":"Lett Appl Microbiol"},{"key":"2694_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-765X.2004.01499.x","author":"H Chart","year":"2004","unstructured":"Chart H, Perry NT. The serological response to Verocytotoxigenic Escherichia coli in patients with haemolytic uraemic syndrome. Lett Appl Microbiol. 2004. https:\/\/doi.org\/10.1111\/j.1472-765X.2004.01499.x.","journal-title":"Lett Appl Microbiol."},{"key":"2694_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1128\/JCM.02262-14","volume":"53","author":"LJ Melli","year":"2015","unstructured":"Melli LJ, Ciocchini AE, Caillava AJ, Vozza N, Chinen I, Rivas M, et al. Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome. J Clin Microbiol. 2015;53:528\u201338.","journal-title":"J Clin Microbiol"},{"key":"2694_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(03)00079-9","author":"CM Szymanski","year":"2003","unstructured":"Szymanski CM, Logan SM, Linton D, Wren BW. Campylobacter - a tale of two protein glycosylation systems. Trends Microbiol. 2003. https:\/\/doi.org\/10.1016\/S0966-842X(03)00079-9.","journal-title":"Trends Microbiol."},{"key":"2694_CR27","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1073\/pnas.0500044102","volume":"102","author":"MF Feldman","year":"2005","unstructured":"Feldman MF, Wacker M, Hernandez M, Hitchen PG, Marolda CL, Kowarik M, et al. Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc Natl Acad Sci. 2005;102:3016\u201321.","journal-title":"Proc Natl Acad Sci"},{"key":"2694_CR28","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.1073\/pnas.0509207103","volume":"103","author":"M Wacker","year":"2006","unstructured":"Wacker M, Feldman MF, Callewaert N, Kowarik M, Clarke BR, Pohl NL, et al. Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems. Proc Natl Acad Sci. 2006;103:7088\u201393.","journal-title":"Proc Natl Acad Sci"},{"key":"2694_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1475-2859-11-13","volume":"11","author":"JA Iwashkiw","year":"2012","unstructured":"Iwashkiw JA, Fentabil MA, Faridmoayer A, Mills DC, Peppler M, Czibener C, et al. Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis. Microb Cell Fact. 2012;11:13. https:\/\/doi.org\/10.1186\/1475-2859-11-13.","journal-title":"Microb Cell Fact"},{"key":"2694_CR30","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1128\/JCM.00151-16","volume":"54","author":"ME Cortina","year":"2016","unstructured":"Cortina ME, Balzano RE, Serantes DAR, Caillava AJ, Elena S, Ferreira AC, et al. A bacterial glycoengineered antigen for improved serodiagnosis of porcine brucellosis. J Clin Microbiol. 2016;54:1448\u201355.","journal-title":"J Clin Microbiol"},{"key":"2694_CR31","doi-asserted-by":"publisher","first-page":"e2048","DOI":"10.1371\/journal.pntd.0002048","volume":"7","author":"AE Ciocchini","year":"2013","unstructured":"Ciocchini AE, Rey Serantes DA, Melli LJ, Iwashkiw JA, Deodato B, Wallach J, et al. Development and validation of a novel diagnostic test for human brucellosis using a glyco-engineered antigen coupled to magnetic beads. PLoS Negl Trop Dis. 2013;7:e2048.","journal-title":"PLoS Negl Trop Dis."},{"key":"2694_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.vetmic.2014.04.014","volume":"172","author":"AE Ciocchini","year":"2014","unstructured":"Ciocchini AE, Serantes DAR, Melli LJ, Guidolin LS, Iwashkiw JA, Elena S, et al. A bacterial engineered glycoprotein as a novel antigen for diagnosis of bovine brucellosis. Vet Microbiol. 2014;172:455\u201365.","journal-title":"Vet Microbiol."},{"key":"2694_CR33","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1111\/jam.15556","volume":"132","author":"A Novak","year":"2022","unstructured":"Novak A, Melli LJ, Rey Serantes DA, Caillava AJ, Comerci DJ, Ugalde JE, et al. Development of a novel glycoprotein-based immunochromatographic test for the rapid serodiagnosis of bovine brucellosis. J Appl Microbiol. 2022;132:4277\u201388.","journal-title":"J Appl Microbiol."},{"key":"2694_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.tibtech.2013.03.003","volume":"31","author":"JL Baker","year":"2013","unstructured":"Baker JL, Elik E\u00c7, Delisa MP. Expanding the glycoengineering toolbox: the rise of bacterial N-linked protein glycosylation. Trends Biotechnol. 2013;31:313\u201323.","journal-title":"Trends Biotechnol"},{"key":"2694_CR35","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.130002","volume":"3","author":"J Cuccui","year":"2013","unstructured":"Cuccui J, Thomas RM, Moule MG, D\u2019Elia RV, Laws TR, Mills DC, et al. Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis. Open Biol. 2013;3: 130002.","journal-title":"Open Biol"},{"key":"2694_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1475-2859-9-61","volume":"9","author":"J Ihssen","year":"2010","unstructured":"Ihssen J, Kowarik M, Dilettoso S, Tanner C, Wacker M, Th\u00f6ny-Meyer L. Production of glycoprotein vaccines in Escherichia coli. Microb Cell Fact. 2010;9:61.","journal-title":"Microb Cell Fact"},{"key":"2694_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2014.00381","volume":"5","author":"F Garcia-Quintanilla","year":"2014","unstructured":"Garcia-Quintanilla F, Iwashkiw JA, Price NL, Stratilo C, Feldman MF. Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery. Front Microbiol. 2014;5:1\u201310.","journal-title":"Front Microbiol"},{"key":"2694_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12934-015-0195-7","volume":"14","author":"MM K\u00e4mpf","year":"2015","unstructured":"K\u00e4mpf MM, Braun M, Sirena D, Ihssen J, Th\u00f6ny-Meyer L, Ren Q. In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation. Microb Cell Fact. 2015;14:12.","journal-title":"Microb Cell Fact"},{"key":"2694_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10719-012-9451-9","volume":"30","author":"M Wetter","year":"2013","unstructured":"Wetter M, Kowarik M, Steffen M, Carranza P, Corradin G, Wacker M. Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component. Glycoconj J. 2013;30:511\u201322.","journal-title":"Glycoconj J."},{"key":"2694_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/glycob\/cwz044","volume":"29","author":"N Ravenscroft","year":"2019","unstructured":"Ravenscroft N, Braun M, Schneider J, Dreyer AM, Wetter M, Haeuptle MA, et al. Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate. Glycobiology. 2019;29:669\u201380.","journal-title":"Glycobiology"},{"key":"2694_CR41","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10719-021-09985-9","volume":"38","author":"M Kowarik","year":"2021","unstructured":"Kowarik M, Wetter M, Haeuptle MA, Braun M, Steffen M, Kemmler S, et al. The development and characterization of an E. coli O25B bioconjugate vaccine. Glycoconj J. 2021;38:421\u201335.","journal-title":"Glycoconj J."},{"key":"2694_CR42","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1016\/j.vaccine.2009.06.013","volume":"27","author":"CE Frasch","year":"2009","unstructured":"Frasch CE. Preparation of bacterial polysaccharide \u2013 protein conjugates: analytical and manufacturing challenges. Vaccine. 2009;27:6468\u201370.","journal-title":"Vaccine"},{"key":"2694_CR43","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/bit.26953","volume":"116","author":"AJ Caillava","year":"2019","unstructured":"Caillava AJ, Ortiz GE, Melli LJ, Ugalde JE, Ciocchini AE, Comerci DJ. Improving bioreactor production of a recombinant glycoprotein in Escherichia coli: effect of specific growth rate on protein glycosylation and specific productivity. Biotechnol Bioeng. 2019;116:1427\u201338.","journal-title":"Biotechnol Bioeng."},{"key":"2694_CR44","doi-asserted-by":"publisher","DOI":"10.1021\/ac1027116","author":"MHJ Selman","year":"2011","unstructured":"Selman MHJ, Hemayatkar M, Deelder AM, Wuhrer M. Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides. Anal Chem. 2011. https:\/\/doi.org\/10.1021\/ac1027116.","journal-title":"Anal Chem"},{"key":"2694_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0008-6215(95)00333-9","volume":"281","author":"MC Manca","year":"1996","unstructured":"Manca MC, Weintraub A, Widmalm G. Structural studies of the Escherichia coli O26 O-antigen polysaccharide. Carbohydr Res. 1996;281:155\u201360.","journal-title":"Carbohydr Res."},{"key":"2694_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0008-6215(95)00243-6","volume":"278","author":"B Jann","year":"1995","unstructured":"Jann B, Shashkov A, Torgov V, Kochanowski H, Seltmann G, Jann K. NMR investigation of the 6-deoxy-l-talose-containing O45, O45-related (O45rel), and O66 polysaccharides of Escherichia coli. Carbohydr Res. 1995;278:155\u201365.","journal-title":"Carbohydr Res."},{"key":"2694_CR47","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/glycob\/cwq015","volume":"20","author":"B Liu","year":"2010","unstructured":"Liu B, Perepelov AV, Svensson MV, Shevelev SD, Guo D, Senchenkova SN, et al. Genetic and structural relationships of Salmonella O55 and Escherichia coli O103 O-antigens and identification of a 3-hydroxybutanoyltransferase gene involved in the synthesis of a Fuc3N derivative. Glycobiology. 2010;20:679\u201388.","journal-title":"Glycobiology"},{"key":"2694_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0008-6215(83)88313-X","volume":"111","author":"L Kenne","year":"1983","unstructured":"Kenne L, Lindberg B, S\u00f6derholm E, Bundle DR, Griffith DW. Structural studies of the O-antigens from Salmonella greenside and Salmonella adelaide. Carbohydr Res. 1983;111:289\u201396.","journal-title":"Carbohydr Res."},{"key":"2694_CR49","unstructured":"Bolet\u00edn Integrado de Vigilancia No.560 SE 30\/2021. https:\/\/bancos.salud.gob.ar\/recurso\/boletin-integrado-de-vigilancia-n560-se30-2021. 2021. p. 59\u201369."},{"key":"2694_CR50","doi-asserted-by":"publisher","first-page":"e010003","DOI":"10.1128\/jcm.01003-24","volume":"62","author":"SM Landivar","year":"2024","unstructured":"Landivar SM, Melli LJ, Maiztegui C, Schesi C, Baschkier A, Francisetti V, et al. A novel multiplex and glycoprotein-based immunochromatographic serologic IgM test for the rapid diagnosis of Escherichia coli O157 and O145 causing bloody diarrhea and hemolytic uremic syndrome. J Clin Microbiol. 2024;62:e010003-e10024.","journal-title":"J Clin Microbiol."},{"key":"2694_CR51","unstructured":"Ministerio de Salud. Bolet\u00edn integrado de vigilancia N\u00b0702 SE17\/2024. 2024. https:\/\/www.argentina.gob.ar\/sites\/default\/files\/2024\/04\/ben-702-se17.pdf"},{"key":"2694_CR52","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1099\/jmm.0.001215","volume":"69","author":"C Jenkins","year":"2020","unstructured":"Jenkins C, Byrne L, Vishram B, Sawyer C, Balasegaram S, Ahyow L, et al. Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England PERSONAL VIEW. J Med Microbiol. 2020;69:1034\u20136.","journal-title":"J Med Microbiol"},{"key":"2694_CR53","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.nefro.2015.07.005","volume":"35","author":"JM Campistol","year":"2015","unstructured":"Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, et al. Actualizaci\u00f3n en s\u00edndrome hemol\u00edtico ur\u00e9mico at\u00edpico: diagn\u00f3stico y tratamiento. Documento de consenso Nefrolog\u00eda. 2015;35:421\u201347.","journal-title":"Documento de consenso. Nefrolog\u00eda."},{"key":"2694_CR54","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1128\/JCM.00817-11","volume":"49","author":"DL Kiska","year":"2011","unstructured":"Kiska DL, Riddell SW. Should all stools be screened for Shiga toxin-producing Escherichia coli? J Clin Microbiol. 2011;49:2390\u20137.","journal-title":"J Clin Microbiol."},{"key":"2694_CR55","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1086\/341781","volume":"186","author":"K Ludwig","year":"2002","unstructured":"Ludwig K, Bitzan M, Bobrowski C, M\u00fcller-Wiefel DE. Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome. J Infect Dis. 2002;186:566\u20139.","journal-title":"J Infect Dis"},{"key":"2694_CR56","unstructured":"Commission Implementing Decision 2018\/945. On the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. Official Journal of the European Union. 2018;1\u201374."},{"key":"2694_CR57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0378-1119(95)00584-1","volume":"166","author":"ME Kovach","year":"1995","unstructured":"Kovach ME, Elzer PH, Steven Hill D, Robertson GT, Farris MA, Roop RM, et al. Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene. 1995;166:175\u20136.","journal-title":"Gene"},{"key":"2694_CR58","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1128\/jb.134.3.1141-1156.1978","volume":"134","author":"ACY Chang","year":"1978","unstructured":"Chang ACY, Cohen SN. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol. 1978;134:1141\u201356.","journal-title":"J Bacteriol."},{"issue":"5969","key":"2694_CR59","first-page":"64","volume":"68","author":"MD Lefebre","year":"2002","unstructured":"Lefebre MD, Valvano MA. Construction and evaluation of plasmid vectors optimized for constitutive and regulated gene expression in Burkholderia cepacia complex isolates. Appl Environ Microbiol. 2002;68(5969):64.","journal-title":"Appl Environ Microbiol."}],"container-title":["Microbial Cell Factories"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-025-02694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12934-025-02694-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-025-02694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:03:05Z","timestamp":1747767785000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbialcellfactories.biomedcentral.com\/articles\/10.1186\/s12934-025-02694-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2694"],"URL":"https:\/\/doi.org\/10.1186\/s12934-025-02694-0","relation":{},"ISSN":["1475-2859"],"issn-type":[{"value":"1475-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A patent has been filed regarding the diagnostic application of recombinant glycoproteins.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}